Dialysis: Hypokalaemia and cardiac risk in peritoneal dialysis patients

Nature Reviews Nephrology

Volumn 8, Issue 9, 2012, Pages 501-503

  Kwan, Bonnie Ching Ha ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM;

CARDIOVASCULAR RISK; DEATH; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPOKALEMIA; KIDNEY CLEARANCE; KIDNEY FUNCTION; MORTALITY; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; SURVIVAL; ULTRAFILTRATION;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; HYPOKALEMIA; KIDNEY FAILURE, CHRONIC; LONG-TERM CARE; MALE; PERITONEAL DIALYSIS; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84865525779     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.159     Document Type: Review

References (9)

1. Torlén, K., Kalantar-Zadeh, K., Molnar, M. Z., Vashistha, T. & Mehrotra, R. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin. J. Am. Soc. Nephrol. http://dx.doi.org/10.2215/CJN. 00960112.
2. Szeto, C. C. et al. Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. Am. J. Kidney Dis. 46, 128-135 (2005
3. Chuang, Y. W., Shu, K. H., Yu, T. M., Cheng, C. H. & Chen, C. H. Hypokalaemia: An independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol. Dial. Transplant. 24, 1603-1608 (2009
4. McIntyre, C. W. et al. Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 133-141 (2011
5. Zhang, H. et al. Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects dayofweek mortality. Kidney Int. 81, 1108-1115 (2012
6. Van Buren, P. N., Shastri, S. & Inrig, J. K. New perspectives on blood pressure variability in hemodialysis patients. Am. J. Kidney Dis. 59, 333-335 (2012
7. Mirani, M. et al. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis. Diabetes Technol. Ther. 12, 749-753 (2010
8. Pisoni, R. L. et al. Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices. Am. J. Kidney Dis. 57, 266-275 (2011
9. De Paola, L., Coppolino, G., Bolignano, D., Buemi, M. & Lombardi, L. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study. Ther. Apher. Dial. 14, 566-571 (2010).